Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis
(1) Background: Cystic fibrosis (CF) is a disease with well-documented clinical differences between female and male patients. However, this gender gap is very poorly studied at the molecular level. (2) Methods: Expression differences in whole blood transcriptomics between female and male CF patients are analyzed in order to determine the pathways related to sex-biased genes and assess their potential influence on sex-specific effects in CF patients. (3) Results: We identify sex-biased genes in female and male CF patients and provide explanations for some sex-specific differences at the molecular level. (4) Conclusion: Genes in key pathways associated with CF are differentially expressed between sexes, and thus may account for the gender gap in morbidity and mortality in CF.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Journal of personalized medicine - 13(2023), 6 vom: 31. Mai |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gärtner, Christiane [VerfasserIn] |
---|
Links: |
---|
Themen: |
CAMP signaling pathway |
---|
Anmerkungen: |
Date Revised 01.07.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jpm13060924 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358752256 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358752256 | ||
003 | DE-627 | ||
005 | 20231226075416.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jpm13060924 |2 doi | |
028 | 5 | 2 | |a pubmed24n1195.xml |
035 | |a (DE-627)NLM358752256 | ||
035 | |a (NLM)37373913 | ||
035 | |a (PII)924 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gärtner, Christiane |e verfasserin |4 aut | |
245 | 1 | 0 | |a Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.07.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a (1) Background: Cystic fibrosis (CF) is a disease with well-documented clinical differences between female and male patients. However, this gender gap is very poorly studied at the molecular level. (2) Methods: Expression differences in whole blood transcriptomics between female and male CF patients are analyzed in order to determine the pathways related to sex-biased genes and assess their potential influence on sex-specific effects in CF patients. (3) Results: We identify sex-biased genes in female and male CF patients and provide explanations for some sex-specific differences at the molecular level. (4) Conclusion: Genes in key pathways associated with CF are differentially expressed between sexes, and thus may account for the gender gap in morbidity and mortality in CF | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a SABV | |
650 | 4 | |a cAMP signaling pathway | |
650 | 4 | |a cystic fibrosis | |
650 | 4 | |a differential gene expression | |
650 | 4 | |a estrogen signaling pathway | |
650 | 4 | |a gender gap | |
650 | 4 | |a sex bias | |
700 | 1 | |a Fallmann, Jörg |e verfasserin |4 aut | |
700 | 1 | |a Stadler, Peter F |e verfasserin |4 aut | |
700 | 1 | |a Kaiser, Thorsten |e verfasserin |4 aut | |
700 | 1 | |a Berkemer, Sarah J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of personalized medicine |d 2011 |g 13(2023), 6 vom: 31. Mai |w (DE-627)NLM228113881 |x 2075-4426 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2023 |g number:6 |g day:31 |g month:05 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jpm13060924 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2023 |e 6 |b 31 |c 05 |